AI-generated summary
The authors reviewed PubMed literature on photobiomodulation therapy for chemotherapy-induced peripheral neuropathy and included three eligible articles. They report that primary outcome measures varied widely across the studies and that PBMT might be an effective strategy, but evidence is limited. The authors call for more methodologically uniform research, especially on PBMT parameters.
- Studies included
- 3
- Who or what was studied
- Patients with chemotherapy-induced peripheral neuropathy
- Limits stated in the abstract
- The abstract states that only three articles were included, primary outcome measures were highly variable, and evidence is limited.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Neuropathy, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.